Potential biomarkers for the diagnosis of stroke

References

• Saver J. Proposal for a universal definition of cerebral infarction. Stroke39(11), 3110–3115 (2008).
   PubMed Web of Science ®Google Scholar
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N. Engl. J. Med.333(24), 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359(13), 1317–1329 (2008).
   PubMed Web of Science ®Google Scholar
• Furlan A, Higashida R, Wechsler L et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA282(21), 2003–2011 (1999).
   PubMed Web of Science ®Google Scholar
• Stead L, Gilmore R, Bellolio M, Rabinstein A, Decker W. Percutaneous clot removal devices in acute ischemic stroke: a systematic review and meta-analysis. Arch. Neurol.65(8), 1024–1030 (2008).
   PubMedGoogle Scholar
• Whiteley W, Tseng M, Sandercock P. Blood biomarkers in the diagnosis of ischemic stroke: a systematic review. Stroke39(10), 2902–2909 (2008).
   PubMed Web of Science ®Google Scholar
• Ruzak-Skocir B, Trbojevic-Cepe M. Study of serum and cerebrospinal fluid enzymes in diagnosis and differential diagnosis of cerebrovascular diseases. Neurologija39(4), 239–250 (1990).
   PubMedGoogle Scholar
• Anand N, Stead L. Neuron-specific enolase as a marker for acute ischemic stroke: a systematic review. Cerebrovasc. Dis.20(4), 213–219 (2005).
   PubMed Web of Science ®Google Scholar
• Bigal M, Lipton R. Clinical course in migraine: conceptualizing migraine transformation. Neurology71(11), 848–855 (2008).
   PubMed Web of Science ®Google Scholar
• Laskowitz D, Kasner S, Saver J et al. Clinical usefulness of a biomarker-based diagnostic test for acute stroke. The Biomarker Rapid Assessment in Ischemic Injury (BRAIN) study. Stroke40(1), 77–85 (2008).
   PubMedGoogle Scholar
• Brown M, O’Brien W, Wong T et al. Neurocardiogenic effects of acute ischaemic stroke on left ventricular function. Heart Lung Circ.17(Suppl. 3), S88–S89 (2008).
   Google Scholar
• Peeters W, Hellings W, de Kleijn D et al. Carotid atherosclerotic plaques stabilize after stroke. insights into the natural process of atherosclerotic plaque stabilization. Arterioscler. Thromb. Vasc. Biol.29(1), 128–133 (2008).
   PubMedGoogle Scholar
• Tang Y, Lu A, Aronow B, Wagner K, Sharp F. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur. J. Neurosci.15(12), 1937–1952 (2002).
   PubMed Web of Science ®Google Scholar
• Tang Y, Nee A, Lu A, Ran R, Sharp F. Blood genomic expression profile for neuronal injury. J. Cereb. Blood Flow Metab.23(3), 310–319 (2003).
   PubMed Web of Science ®Google Scholar
• Xu H, Tang Y, Liu D et al. Gene expression in peripheral blood differs after cardioembolic compared with large-vessel atherosclerotic stroke: biomarkers for the etiology of ischemic stroke. J. Cereb. Blood Flow Metab.28(7), 1320–1328 (2008).
   PubMed Web of Science ®Google Scholar
• Lamers K, Vos P, Verbeek M, Rosmalen F, van Geel W, van Engelen B. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res. Bull.61(3), 261–264 (2003).
   PubMed Web of Science ®Google Scholar
• Missler U, Wiesmann M, Friedrich C, Kaps M. S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke28(10), 1956–1960 (1997).
   PubMed Web of Science ®Google Scholar
• Reynolds M, Kirchick H, Dahlen J et al. Early biomarkers of stroke. Clin. Chem.49(10), 1733–1739 (2003).
   PubMed Web of Science ®Google Scholar
• Lynch J, Blessing R, White W, Grocott H, Newman M, Laskowitz D. Novel diagnostic test for acute stroke. Stroke35(1), 57–63 (2004).
   PubMed Web of Science ®Google Scholar
• Dambinova S, Khounteev G, Izykenova G, Zavolokov I, Ilyukhina A, Skoromets A. Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem.49(10), 1752–1762 (2003).
   PubMed Web of Science ®Google Scholar
• Allard L, Burkhard P, Lescuyer P et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin. Chem.51(11), 2043–2051 (2005).
   PubMed Web of Science ®Google Scholar
• Powers R, Majors A, Cerula S, Huber H, Schmidt B, Roberts J. Changes in markers of vascular injury in response to transient hyperhomocysteinemia. Metabolism,52(4), 501–507 (2003).
   PubMedGoogle Scholar
• Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke32(1), 133–138 (2001).
   PubMed Web of Science ®Google Scholar
• Arenillas J, Alvarez-Sabín J, Molina C et al. C-reactive protein predicts further ischemic events in first-ever transient ischemic attack or stroke patients with intracranial large-artery occlusive disease. Stroke34(10), 2463–2468 (2003).
   PubMed Web of Science ®Google Scholar
• Leu H, Lin C, Lin W, Wu T, Chen J. Risk stratification and prognostic implication of plasma biomarkers in nondiabetic patients with stable coronary artery disease: the role of high-sensitivity C-reactive protein. Chest126(4), 1032–1039 (2004).
   PubMedGoogle Scholar
• Di Napoli M, Schwaninger M, Cappelli R et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke36(6), 1316–1329 (2005).
   PubMed Web of Science ®Google Scholar
• Rost N, Wolf P, Kase C et al. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke32(11), 2575–2579 (2001).
   PubMed Web of Science ®Google Scholar
• Curb J, Abbott R, Rodriguez B et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation107(15), 2016–2020 (2003).
   PubMed Web of Science ®Google Scholar
• Sotgiu S, Zanda B, Marchetti B et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur. J. Neurol.13(5), 505–513 (2006).
   PubMed Web of Science ®Google Scholar
• Kim J, Yoon S, Kim Y, Ryu J. Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke27(9), 1553–1557 (1996).
   PubMed Web of Science ®Google Scholar
• Fon E, Mackey A, Côté R et al. Hemostatic markers in acute transient ischemic attacks. Stroke25(2), 282–286 (1994).
   PubMed Web of Science ®Google Scholar
• Mauriello A, Sangiorgi G, Palmieri G et al. Hyperfibrinogenemia is associated with specific histocytological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation101(7), 744–750 (2000).
   PubMedGoogle Scholar
• Ernst E, Resch K. Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann. Intern. Med.118(12), 956–963 (1993).
   PubMed Web of Science ®Google Scholar
• Wolff V, Aleil B, Giroud M et al. Soluble platelet glycoprotein V is a marker of thrombosis in patients with ischemic stroke. Stroke36(3), e17–e19 (2005).
   PubMed Web of Science ®Google Scholar